Anifrolumab, a relatively emerging monoclonal antibody, is creating considerable hope within the healthcare community as a potential therapy for various autoimmune disorders. This unique agent targets the immune https://bookmark-template.com/story28715632/anifrolumab-a-novel-approach-for-autoimmune-conditions